Drawing for Serial No. 79340248

USPTO serial 79340248

Serial No. 79340248

Reviewed by CopyMark Law Group

Reg. 7089004Status 700Registered
Filing date
Status date
Registration date
Jun 27, 2023
Examiner
DOMBROW, COLLEEN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79340248?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark I. Peroff

Mark I. Peroff Lerner David LLP20 Commerce DriveCranford, NJ 07016United States

Goods and services

ClassDescriptionStatusFirst use
009Software, namely, downloadable augmented reality software for planning and assessing minimally invasive medical interventions and surgeries and for controlling and guiding medical robots for minimally invasive medical interventions and surgeries; application software, namely, downloadable augmented reality software for planning and assessing minimally invasive medical interventions and surgeries and for controlling and guiding medical robots for minimally invasive medical interventions and surgeries; virtual and augmented reality software, namely, downloadable augmented reality software for planning and assessing minimally invasive medical interventions and surgeries and for controlling and guiding medical robots for minimally invasive medical interventions and surgeries; optical amplification devices, namely, optical semiconductor amplifiers; lasers, not for medical purposes; monitoring devices, namely, electronic monitors for monitoring electric current and electrical signals for use in connection with medical robots; and control devices, namely, remote controls for controlling medical robots; electric sensors and infrared detectors for use in guiding and controlling medical robots; monitoring instruments and apparatus, namely, 3-D spectacles and video monitors.ACTIVE—
010Surgical apparatus and instruments for medical, dental and veterinary use; artificial limbs, eyes and teeth; suture materials; medical apparatus and instruments, namely, surgical robots and medical robots for use in medical interventions in the nature of minimally invasive surgeries; medical diagnostic apparatus, namely, medical robots for use in medical imaging for diagnosing medical conditions; examination apparatus, namely, medical robots for use in medical imaging for diagnosing medical conditions; monitoring apparatus, namely, medical robots for use in medical imaging for diagnosing medical conditions; medical radiation apparatus; medical probes, namely, namely, medical robots for use in exploratory medical imaging for diagnosing medical conditions; surgical robots; medical imaging apparatus; surgical instruments and apparatus in the nature of position indicators for collimators for surgical purposes; medical fixing devices not of metal for external stabilization of the patient during minimally invasive treatments, namely, clamps for surgical use; medical instruments and devices, in particular for minimally invasive interventions, namely, surgical robots and medical robots for use in medical interventions in the nature of minimally invasive surgeries; medical navigation and referencing devices, namely, medical imaging apparatusACTIVE—
035Retail and wholesale store services featuring medical apparatus and instruments, diagnostic, examination and monitoring apparatus, medical radiation equipment, medical probes, surgical robots, surgical, medical, dental and veterinary instruments and apparatus, artificial limbs, eyes and teeth, orthopedic articles, suture materials, medical imaging apparatus, position indicators for collimators for surgical purposes, non-metal medical fixation devices for external stabilization of the patient during minimally invasive treatments, medical instruments and devices, in particular for minimally invasive interventions, medical navigation and referencing devices, downloadable augmented reality software for planning and assessing minimally invasive medical interventions and surgeries and for controlling and guiding medical robots for minimally invasive medical interventions and surgeries, scientific and laboratory equipment for physical reactions by means of electricity, optical amplification devices, lasers, measurement, detection, monitoring and control devices, sensors, detectors, and monitoring instruments and apparatusACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 18, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 26, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 26, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 26, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Apr 26, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 26, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 26, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 26, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Apr 26, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 26, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 24, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 28, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 28, 2023FIMPFINAL DISPOSITION PROCESSED—
Sep 27, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 27, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 27, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 25, 2023GPNXNOTIFICATION PROCESSED BY IB—
Apr 11, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 11, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 5, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 5, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 22, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 9, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 9, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Mar 9, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 9, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 9, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 6, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 6, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 8, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 7, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 7, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 4, 2023RFNTREFUSAL PROCESSED BY IB—
Dec 9, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 9, 2022RFRRREFUSAL PROCESSED BY MPU—
Sep 28, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 27, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2022DOCKASSIGNED TO EXAMINER—
May 17, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
May 13, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 12, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance